Oncotarget

Meta-Analysis:

Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis

Alexey Surov _, Hans Jonas Meyer and Andreas Wienke

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:59492-59499. https://doi.org/10.18632/oncotarget.17752

Metrics: PDF 1717 views  |   HTML 2061 views  |   ?  


Abstract

Alexey Surov1,*, Hans Jonas Meyer1,* and Andreas Wienke2,*

1 Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany

2Institute of Medical Epidemiology, Biostatistics, and Informatics, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

*All authors contributed equally for this work

Correspondence to:

Alexey Surov, email: Alexey.Surov@medizin.uni-leipzig.de

Keywords: DWI, MRI, ADC, cellularity, tumor

Received: March 31, 2017     Accepted: April 27, 2017     Published: May 10, 2017

ABSTRACT

The purpose of this meta-analysis was to provide clinical evidence regarding relationship between ADC and cellularity in different tumors based on large patient data.

Medline library was screened for associations between ADC and cell count in different tumors up to September 2016. Only publications in English were extracted. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA) was used for the research.

Overall, 39 publications with 1530 patients were included into the analysis. The following data were extracted from the literature: authors, year of publication, number of patients, tumor type, and correlation coefficients.

The pooled correlation coefficient for all studies was ρ = -0.56 (95 % CI = [−0.62; −0.50]),. Correlation coefficients ranged from ρ =−0.25 (95 % CI = [−0.63; 0.12]) in lymphoma to ρ=−0.66 (95 % CI = [−0.85; −0.47]) in glioma. Other coefficients were as follows: ovarian cancer, ρ = −0.64 (95% CI = [−0.76; −0.52]); lung cancer, ρ = −0.63 (95 % CI = [−0.78; −0.48]); uterine cervical cancer, ρ = −0.57 (95 % CI = [−0.80; −0.34]); prostatic cancer, ρ = −0.56 (95 % CI = [−0.69; −0.42]); renal cell carcinoma, ρ = −0.53 (95 % CI = [−0.93; −0.13]); head and neck squamous cell carcinoma, ρ = −0.53 (95 % CI = [-0.74; −0.32]); breast cancer, ρ = −0.48 (95 % CI = [−0.74; −0.23]); and meningioma, ρ = -0.45 (95 % CI = [−0.73; −0.17]).


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 17752